Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Anti-depressant crystalline paroxetine hydrochloride hemihydrate|
|Abstract:||The invention provides crystalline paroxetine hydrochloride hemihydrate, processes for its preparation, compositions containing the same and its therapeutic use as an anti-depressant.|
|Inventor(s):||Barnes; Roger D. (Betchworth, GB2), Wood-Kaczmar; Marian W. (Harlow, GB2), Curzons; Alan D. (Worthing, GB2), Lynch; Ian R. (Epsom, GB2), Richardson; John E. (Harlow, GB2), Buxton; Philip C. (Epsom, GB2)|
|Assignee:||Beecham Group p.l.c. (Brentford, GB2)|
Patent Claim Types:|
see list of patent claims
|Compound; Process; Composition; Use;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Finland||87785||<disabled in preview>|
|Denmark||508786||<disabled in preview>|
|Denmark||171694||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.